| 主要論文・著書 |
論文
- Otani K, Tokudome T, Kamiya CA, Mao Y, Nishimura H, Hasegawa T, et al. Deficiency of cardiac natriuretic peptide signaling promotes peripartum cardiomyopathy-like remodeling in the mouse heart. Circulation 2020; 141:571-588.
- Ohshima M, Coq JO, Otani K, Hattori Y, Ogawa Y, Sato Y et al. Mild intrauterine hypoperfusion reproduces neurodevelopmental disorders observed in prematurity. Sci Rep 2016;6:39377.
- Tokudome T, Kishimoto I, Shindo T, Kawakami H, Koyama T, Otani K, et al. Importance of endogenous atrial and brain natriuretic peptides in murine embryonic vascular and organ development. Endocrinology 2016;157;358-67.
- Mao Y, Tokudome T, Kishimoto I, Otani K, Nishimura H, Yamaguchi O et al. Endogenous ghrelin attenuates pressure overload-induced cardiac hypertrophy via a cholinergic anti-inflammatory pathway. Hypertension 2015;65:1238-44.
- Nojiri T, Hosoda H, Tokudome T, Miura K, Ishikane S, Otani K et al. Atrial natriuretic peptide prevents cancer metastasis though vascular endothelial cells. Proc Natl Acad Sci USA 2015;112:4086-91.
- Yoshihara F, Tokudome T, Kishimoto I, Otani K, Kuwabara A, Horio T et al. Aggravated renal tubular damage and interstitial fibrosis in mice lacking guanylyl cyclase-A (GC-A), a receptor for atrial and B-type natriuretic peptides. Clin Exp Nephrol 2015;19:197-207.
- Mao Y, Tokudome T, Kishimoto I, Otani K, Miyazato M, Kangawa K. One dose of oral hexarelin protects cardiac function fourteen days after experimental myocardial infarction in male mice. Peptides 2014;56:156-62.
- Mao Y, Tokudome T, Kishimoto I, Otani K, Hosoda H, Nagai C et al. Hexarelin treatment in male ghrelin knockout mice after myocardial infarction. Endocrinology 2013;154:3847-54.
- Tsuda H, Yamahara K, Otani K, Okumi M, Yazawa K, Kaimori J et al. Transplantation of allogenic fetal membrane-derived mesenchymal stem cells protect against ischemia-reperfusion-induced acute kidney injury. Cell Transplant 2014;23:889-99.
- Otani K, Yamahara K. Feasibility of lactadherin-bearing clinically available microbubbles as ultrasound contrast agent for angiogenesis. Mol Imaging Biol 2013;15:534-41.
- Mao Y, Tokudome T, Otani K, Kishimoto I, Miyazato M, Kangawa K. Excessive sympathoactivation and deteriorated heart function after myocardial infarction in male ghrelin knockout mice. Endocrinology 2013;154:1854-63.
- Otani K, Yamahara K. Development of antibody-carrying microbubbles based on clinically available ultrasound contrast agent for targeted molecular imaging: a preliminary chemical study. Mol Imaging Biol 2011;13:250-256.
- Otani K, Yamahara K, Ohnishi S, Obata H, Kitamura S, Nagaya N. Nonviral delivery of siRNA into mesenchymal stem cells by a combination of ultrasound and microbubbles. J Control Release 2009;133:146-53.
その他の論文は下記リンクよりご覧いただけます。
（外部リンク）http://www.ncbi.nlm.nih.gov/pubmed/ ?term=kentaro+otani
著書
- Otani K (2011). Feasibility of clinical application of ultrasound molecular imaging, Ultrasound Imaging - Medical Applications. Igor V. Minin and Oleg V. Minin (Ed.), InTech.
|
|---|
